Fibroblast-directed expression and localization of 92-kDa type IV collagenase along the tumor-stroma interface in an in vitro three-dimensional model of human squamous cell carcinoma

1997 ◽  
Vol 19 (4) ◽  
pp. 258-266 ◽  
Author(s):  
Alexander H. Borchers ◽  
Heinrich Steinbauer ◽  
Birgit S. Schafer ◽  
Michael Kramer ◽  
G. Tim Bowden ◽  
...  
2020 ◽  
Vol 20 (4) ◽  
pp. 484-490
Author(s):  
Mohammad Rasool Khazaei ◽  
Zahra Rashidi ◽  
Farzaneh Chobsaz ◽  
Elham Niromand ◽  
Mozafar Khazaei

Molecules ◽  
2019 ◽  
Vol 24 (9) ◽  
pp. 1793 ◽  
Author(s):  
Silvia Tampucci ◽  
Sara Carpi ◽  
Maria Digiacomo ◽  
Beatrice Polini ◽  
Stefano Fogli ◽  
...  

In this work, hybrid compounds 1–4 obtained by conjugation of the non-steroidal anti-inflammatory drug diclofenac, with natural molecules endowed with antioxidant and antiproliferative activity were prepared. The antiproliferative activity of these hybrids was evaluated on immortalized human keratinocyte (HaCaT) cells stimulated with epidermal growth factor (EGF), an actinic keratosis (AK) model, and on human squamous cell carcinoma (SCC) cells (A431). Hybrid 1 presented the best activity in both cell models. Self-assembling surfactant nanomicelles have been chosen as the carrier to drive the hybrid 1 into the skin; the in vitro permeation through and penetration into pig ear skin have been evaluated. Among the nanostructured formulations tested, Nano3Hybrid20 showed a higher tendency of the hybrid 1 to be retained in the skin rather than permeating it, with a desirable topical and non-systemic action. On these bases, hybrid 1 may represent an attractive lead scaffold for the development of new treatments for AK and SCC.


1991 ◽  
Vol 56 (2) ◽  
pp. 147-152 ◽  
Author(s):  
C. Kandaswami ◽  
E. Perkins ◽  
D.S. Soloniuk ◽  
G. Drzewiecki ◽  
E. Middleton

1996 ◽  
Vol 109 (1-2) ◽  
pp. 23-32 ◽  
Author(s):  
Genevieve Griffon-Etienne ◽  
Jean-Louis Merlin ◽  
Christian Marchal

2007 ◽  
Vol 189 (14) ◽  
pp. 5379-5382 ◽  
Author(s):  
Clément Barjon ◽  
Karine Wecker ◽  
Nadia Izadi-Pruneyre ◽  
Philippe Delepelaire

ABSTRACT On the basis of the three-dimensional model of the heme/hemophore TonB-dependent outer membrane receptor HasR, mutants with six-residue deletions in the 11 putative extracellular loops were generated. Although all mutants continued to be active TonB-dependent heme transporters, mutations in three loops abolished hemophore HasA binding both in vivo and in vitro.


Sign in / Sign up

Export Citation Format

Share Document